Company intelligence / Profile preview
Vyripharm International
Houston, Texas, United States
- Ownership
- Private
- Employees
- ~3
- Development stage
- Other
01
Overview
Vyripharm’s theranostic and precision medicine programs are described as being in development and capable of taking compounds through Phase 0, with partnering for Phase I–III trials; public sources do not report any completed human clinical trials or approved products yet[4][6].
- Therapeutic areas
- OncologyNeurologyPsychiatryInfectious Diseases
- Modalities
- RadiopharmaceuticalSmall moleculeDiagnostic imaging agentVaccineNanoparticle
- Industry
- Biotech
02
Drug pipeline
15 assets14 more assets in the full pipeline.
Request access →03
Partnerships
ABB Robotics (automated laboratory testing and QC platform for biopharma supply chain)[1]Regis Technologies (cGMP manufacture of antiviral agents for diagnostic evaluation of COVID-19)[3]National Yang-Ming University (now National Yang Ming Chiao Tung University) for development of VYR-206 as a diagnostic approach for neurological disorders outcomes[3][6]
Beyond the preview
Go deeper on Vyripharm International.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vyripharm International.